AXGN vs VTR · rev $131.2M vs P/E 149, rev $1.73B
Axogen Inc (AXGN) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Axogen Inc (AXGN) is a medical devices company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported AXGN revenue for 2026-06-30 was $131.2M. Net income was -$21.1M. AXGN currently screens at market cap $497.8M.
Latest reported VTR revenue for 2026-06-30 was $1.73B. Net income was $72.2M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
AXGN currently screens at market cap $497.8M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the AXGN and VTR stock pages for the full models.
Not investment advice.